Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo

Journal of Steroid Biochemistry and Molecular Biology

Volumn 84, Issue 2-3, 2003, Pages 337-342

  Ireson, Christopher R ^a   Parish, David ^a   Purohit, Atul ^a   Woo, Lawrence W L ^b   Potter, Barry V L ^b   Chander, Surinder K ^a   Reed, Michael J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

667 COUMARIN; 667 COUMATE; High performance liquid chromatography

Indexed keywords

667 COUMATE; COUMARIN DERIVATIVE; ETHER; UNCLASSIFIED DRUG;

ACCURACY; ACIDIFICATION; BODY FLUID; CONFERENCE PAPER; DEVICE; DRUG DETERMINATION; DRUG ISOLATION; DRUG SCREENING; DRUG STABILITY; DRUG STORAGE; HUMAN; METABOLITE; PH; PLASMA; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; SENSITIVITY ANALYSIS; STORAGE TEMPERATURE; TECHNIQUE;

EID: 0037323101     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00047-5     Document Type: Conference Paper

References (10)

1. James V.H.T., Reed M.J. Steroid hormones and human cancer. Prog. Cancer Res. Ther. 14:1980;471-487.
2. M.J. Reed, A. Purohit, Sulphatase inhibitors: the rationale for the development of a new endocrine therapy, Rev. Endocr. Rel. Cancer (1993) 51-62.
3. Purohit A., Williams G.J., Roberts C.J., Potter B.V.L., Reed M.J. In vivo inhibition of oestrone sulphagase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int. J. Cancer. 63:1995;106-111.
4. W. Elger, S. Schwarz, A. Hedden, G. Reddersen, B. Schneider, Sulfamates of various estrogens as prodrugs with increased systemic and reduced hepatic estrogenicity at oral application, J. Steroid Biochem. Mol. Biochem. (1995) 395-403.
5. Purohit A., Woo W.L., Potter B.V.L., Reed M.J. In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE. Cancer Res. 60:2000;3394-3396.
6. Woo L.W.L., Purohit A., Reed M.J., Potter B.V.L. Active site-directed inhibition of estrone sulfatase by non-steroidal coumarin sulfamates. J. Med. Chem. 39:1998;1349-1351.
7. Hidalgo Aragones M.I., Purohit A., Parish D., Sahm U.G., Pouton C.W., Potter B.V.L., Reed M.J. Pharmacokinetics of oestrone-3-O-Sulphamate. J. Steroid Biochem. Molec. Biol. 96:1996;611-617.
8. I.J. Hidalgo, T.J. Raub, R.T. Borchardt, Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability, Gastroenterology (1989) 736-749.
9. I.J. Hidalgo, Cultured intestinal epithelial cell models, in: R.T. Borchardt, P.L. Smith, G. Wilson (Eds.), Models for Assessing Drug Absorption and Metabolism, Plenum Press, New York, 1996, pp. 35-50.
10. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestine) absorption in man-fact or myth. Pharm. Res. 14:1997;763-766.